Hims & Hers Health (HIMS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
HIMS jumps 6.0% to $29.38. Closed at $29.38, +5.99% vs the prior close of $27.72. Day range $26.33–$29.65, opened at $26.88.
HIMS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — HIMS jumps 6.0% to $29.38
- Closed at $29.38, +5.99% vs the prior close of $27.72. Day range $26.33–$29.65, opened at $26.88.
- Volume was 16.29M shares, 1.5x its 50-day average of 10.93M.
- Price is +0.1% vs its 50-day average ($29.35) and +7.7% vs its 200-day average ($27.29).
- 52-week range $13.74–$65.30; today's close sits at 30% of that range, 55.0% below the 52-week high.
Oct 14, 2026 — HIMS slides 6.7% to $27.72, a 1-month low, 3 down days in a row
- Closed at $27.72, -6.70% vs the prior close of $29.71. Day range $27.57–$29.68, opened at $29.26.
- Volume was 11.07M shares, 1.0x its 50-day average of 10.93M.
- Price is -5.7% vs its 50-day average ($29.40) and +1.5% vs its 200-day average ($27.32).
- 52-week range $13.74–$65.30; today's close sits at 27% of that range, 57.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HIMS slides 3.0% to $29.71
- Closed at $29.71, -3.04% vs the prior close of $30.64. Day range $28.73–$30.38, opened at $29.83.
- Volume was 9.78M shares, 0.9x its 50-day average of 11.03M.
- Price is +0.8% vs its 50-day average ($29.49) and +8.6% vs its 200-day average ($27.35).
- 52-week range $13.74–$65.30; today's close sits at 31% of that range, 54.5% below the 52-week high.
Oct 12, 2026 — HIMS dips 0.9% to $30.64
- Closed at $30.64, -0.91% vs the prior close of $30.92. Day range $30.33–$31.79, opened at $30.92.
- Volume was 8.94M shares, 0.8x its 50-day average of 11.11M.
- Price is +3.8% vs its 50-day average ($29.51) and +11.9% vs its 200-day average ($27.37).
- 52-week range $13.74–$65.30; today's close sits at 33% of that range, 53.1% below the 52-week high.
Oct 9, 2026 — HIMS jumps 10.2% to $30.92, a 1-month high
- Closed at $30.92, +10.19% vs the prior close of $28.06. Day range $28.31–$31.45, opened at $28.34.
- Volume was 16.03M shares, 1.4x its 50-day average of 11.13M.
- Price is +5.0% vs its 50-day average ($29.45) and +12.9% vs its 200-day average ($27.39).
- 52-week range $13.74–$65.30; today's close sits at 33% of that range, 52.6% below the 52-week high.
Oct 8, 2026 — HIMS slides 5.0% to $28.06
- Closed at $28.06, -5.01% vs the prior close of $29.54. Day range $27.49–$29.62, opened at $29.20.
- Volume was 15.06M shares, 1.3x its 50-day average of 11.41M.
- Price is -4.5% vs its 50-day average ($29.37) and +2.4% vs its 200-day average ($27.41).
- 52-week range $13.74–$65.30; today's close sits at 28% of that range, 57.0% below the 52-week high.
Oct 7, 2026 — HIMS ends flat (+0.2%) to $29.54
- Closed at $29.54, +0.24% vs the prior close of $29.47. Day range $28.75–$29.92, opened at $28.87.
- Volume was 5.46M shares, 0.5x its 50-day average of 11.56M — lighter than usual.
- Price is +0.8% vs its 50-day average ($29.31) and +7.6% vs its 200-day average ($27.45).
- 52-week range $13.74–$65.30; today's close sits at 31% of that range, 54.8% below the 52-week high.
- SEC filings that day: 8-K.
Oct 6, 2026 — HIMS dips 0.7% to $29.47
- Closed at $29.47, -0.67% vs the prior close of $29.67. Day range $29.07–$30.08, opened at $30.08.
- Volume was 8.80M shares, 0.8x its 50-day average of 11.71M.
- Price is +0.6% vs its 50-day average ($29.31) and +7.2% vs its 200-day average ($27.48).
- 52-week range $13.74–$65.30; today's close sits at 31% of that range, 54.9% below the 52-week high.
Oct 5, 2026 — HIMS rises 2.3% to $29.67
- Closed at $29.67, +2.31% vs the prior close of $29.00. Day range $28.80–$30.04, opened at $28.91.
- Volume was 8.00M shares, 0.7x its 50-day average of 12.12M.
- Price is +1.2% vs its 50-day average ($29.32) and +7.9% vs its 200-day average ($27.51).
- 52-week range $13.74–$65.30; today's close sits at 31% of that range, 54.6% below the 52-week high.
Oct 2, 2026 — HIMS dips 1.0% to $29.00
- Closed at $29.00, -1.02% vs the prior close of $29.30. Day range $28.55–$30.61, opened at $30.08.
- Volume was 10.08M shares, 0.8x its 50-day average of 12.57M.
- Price is -1.0% vs its 50-day average ($29.29) and +5.3% vs its 200-day average ($27.54).
- 52-week range $13.74–$65.30; today's close sits at 30% of that range, 55.6% below the 52-week high.
HIMS latest news & SEC filings
Every SEC filing by or about HIMS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Boughton Soleil sold 3,461 shares at $29.06 (≈$100.58K) on Oct 14, 2026; now holds 297,348
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 15, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Okupe Oluyemi sold 2,000 shares at $29.70 (≈$59.40K) on Oct 1, 2026; now holds 234,527
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Boughton Soleil sold 3,461 shares at $29.17 (≈$100.96K) on Sep 30, 2026; now holds 300,809
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 31, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $753.21M (prior year $544.83M) (+38.2% vs Jun 30, 2025)
- Net income: -$86.29M (prior year $42.51M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.37 (prior year $0.17) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Things to know before you trade HIMS
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Feb 23, 2026, Nov 3, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.16% (largest 10.2%). That is a volatile stock.
- Liquidity: about 10.82M shares (≈$317.82M) trade per day on average.
- 52-week position: $29.38 vs a range of $13.74–$65.30 (30% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 24 sales; latest: Oluyemi Okupe sold 29,277 shares on Sep 22, 2026.
- Latest filings: 8-K Oct 7, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Listing: NYSE · industry: Services-Offices & Clinics of Doctors of Medicine.
HIMS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 26.88 | 29.65 | 26.33 | 29.38 | 16.29M |
| Oct 14, 2026 | 29.26 | 29.68 | 27.57 | 27.72 | 11.07M |
| Oct 13, 2026 | 29.83 | 30.38 | 28.73 | 29.71 | 9.78M |
| Oct 12, 2026 | 30.92 | 31.79 | 30.33 | 30.64 | 8.94M |
| Oct 9, 2026 | 28.34 | 31.45 | 28.31 | 30.92 | 16.03M |
| Oct 8, 2026 | 29.20 | 29.62 | 27.49 | 28.06 | 15.06M |
| Oct 7, 2026 | 28.87 | 29.92 | 28.75 | 29.54 | 5.46M |
| Oct 6, 2026 | 30.08 | 30.08 | 29.07 | 29.47 | 8.80M |
| Oct 5, 2026 | 28.91 | 30.04 | 28.80 | 29.67 | 8.00M |
| Oct 2, 2026 | 30.08 | 30.61 | 28.55 | 29.00 | 10.08M |
| Oct 1, 2026 | 29.66 | 29.88 | 28.64 | 29.30 | 7.94M |
| Sep 30, 2026 | 29.16 | 31.03 | 29.09 | 29.79 | 14.52M |
| Sep 29, 2026 | 29.39 | 29.83 | 28.30 | 28.70 | 6.58M |
| Sep 28, 2026 | 29.00 | 29.44 | 28.46 | 28.78 | 6.52M |
| Sep 25, 2026 | 29.48 | 29.76 | 28.57 | 29.42 | 8.19M |
| Sep 24, 2026 | 28.00 | 29.65 | 27.31 | 29.28 | 16.71M |
| Sep 23, 2026 | 30.40 | 30.95 | 28.32 | 28.39 | 11.89M |
| Sep 22, 2026 | 29.95 | 31.81 | 29.22 | 30.43 | 16.65M |
| Sep 21, 2026 | 28.50 | 29.52 | 28.18 | 29.35 | 8.45M |
| Sep 18, 2026 | 28.86 | 29.01 | 27.70 | 27.99 | 9.40M |
About Hims & Hers Health
Hims & Hers Health (HIMS) is listed on the NYSE and classified by the SEC under “Services-Offices & Clinics of Doctors of Medicine”. Its business address is in SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1773751.
HIMS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kofi Owusu Amoo-Gottfried | Director | Aug 14, 2026 |
| Deborah M. Autor | Chief Policy Officer | Aug 20, 2026 |
| Delos M. Cosgrove | Director | Aug 14, 2026 |
| Andrew Dudum | Chief Executive Officer | Aug 27, 2026 |
| Anja Manuel | Director | Aug 14, 2026 |
| Christopher D Payne | Director | Aug 18, 2026 |
| Christiane Pendarvis | Director | Jun 15, 2026 |
| Garcia Andrea G Perez | Director | Aug 14, 2026 |
| Kare Schultz | Director | Aug 18, 2026 |
| David B Wells | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Deborah M. Autor | Chief Policy Officer | Aug 20, 2026 |
| Irene Becklund | PAO | Aug 18, 2026 |
| Soleil Boughton | Chief Legal Officer | Sep 17, 2026 |
| Patrick Harrison Carroll | Chief Medical Officer | Aug 18, 2026 |
| Michael Chi | Chief Operating Officer | Sep 17, 2026 |
| Andrew Dudum | Chief Executive Officer | Aug 27, 2026 |
| Mohamed Elshenawy | CTO | Sep 17, 2026 |
| Oluyemi Okupe | Chief Financial Officer | Sep 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | Oluyemi Okupe | Sale | 29,277 | $29.95 |
| Sep 17, 2026 | Oluyemi Okupe | Sale | 12,313 | $28.82 |
| Sep 16, 2026 | Soleil Boughton | Sale | 6,236 | $27.86 |
| Sep 15, 2026 | Mohamed Elshenawy | Sale | 7,954 | $28.39 |
| Sep 15, 2026 | Michael Chi | Sale | 14,027 | $28.39 |
| Sep 2, 2026 | Soleil Boughton | Sale | 3,458 | $28.33 |
| Aug 19, 2026 | Soleil Boughton | Sale | 25,111 | $27.55 |
| Aug 19, 2026 | Oluyemi Okupe | Sale | 4,938 | $29.99 |
| Aug 18, 2026 | Deborah M. Autor | Sale | 16,773 | $27.85 |
| Aug 17, 2026 | Oluyemi Okupe | Sale | 9,388 | $27.89 |
| Jul 17, 2026 | Oluyemi Okupe | Sale | 7,163 | $31.99 |
| Jul 6, 2026 | Oluyemi Okupe | Sale | 7,163 | $36.49 |
| Jun 22, 2026 | Oluyemi Okupe | Sale | 18,197 | $34.03 |
| Jun 18, 2026 | Patrick Harrison Carroll | Sale | 23,726 | $35.00 |
| Jun 18, 2026 | Oluyemi Okupe | Sale | 55,383 | $35.09 |
HIMS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.35B | $128.37M | 0.51 | $300.01M |
| Dec 31, 2024 | $1.48B | $126.04M | 0.53 | $251.08M |
| Dec 31, 2023 | $872.00M | $-23.55M | -0.11 | $73.48M |
| Dec 31, 2022 | $526.92M | $-65.68M | -0.32 | $-26.53M |
| Dec 31, 2021 | $271.88M | $-107.66M | -0.58 | $-34.41M |
Latest balance sheet: total assets $3.63B, total liabilities $3.30B, cash $609.81M (as of Jun 30, 2026).
HIMS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $31.77 |
| May 11, 2026 | 8-K Item 2.02 (results) | $29.14 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $15.51 |
| Nov 3, 2025 | 8-K Item 2.02 (results) | $44.39 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $63.35 |
| May 5, 2025 | 8-K Item 2.02 (results) | $41.88 |
| Feb 24, 2025 | 8-K Item 2.02 (results) | $51.31 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $20.76 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 26, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Offices & Clinics of Doctors of Medicine
Teladoc Health (TDOC)Starling Oncology (STLN)LifeMD (LFMD)Airsculpt Technologies (AIRS)SBC Medical (SBC)Basel Medical (BMGL)Auna (AUNA)Westin Acquisition (WSTN)Concord Medical Services (CCM)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HIMS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.